Baxion
ScreeningTagsAlerts

Palomino Laboratories Inc.

PALX

Financials

10-QQ2 ended 06/30/2608/05/2610-QQ1 ended 03/31/2605/15/2610-KFY 202503/31/2610-QQ3 ended 09/30/2511/14/2510-QQ2 ended 06/30/2508/07/25

Disclosures

8-K/ACurrent report (amended)10/14/268-KCurrent report08/05/268-KCurrent report07/16/268-KCurrent report05/05/268-KCurrent report04/24/26

Prospectuses and Registrations

424B3Prospectus02/12/26S-1Registration statement (IPO)01/23/26

Proxies

DEF 14ADefinitive proxy10/08/26PRE 14APreliminary proxy09/28/26

Ownership

SC 13D/ABeneficial ownership (amended)08/21/26Form 4Insider transaction08/04/26Form 4Insider transaction04/20/26Form 4Insider transaction04/20/26Form 4Insider transaction10/27/25

Other

DD05/01/26EFFECTRequest for effectiveness02/09/26CORRESPCorrespondence with the SEC02/05/26UPLOADLetter from the SEC01/13/26DRSDRS01/12/26

Latest Filings

8-K/ACurrent report (amended)10/14/26DEF 14ADefinitive proxy10/08/26PRE 14APreliminary proxy09/28/2610-QQ2 ended 06/30/2608/05/268-KCurrent report08/05/26

Ownership

SC 13D/ABeneficial ownership (amended)08/21/26Form 4Insider transaction08/04/26Form 4Insider transaction04/20/26Form 4Insider transaction04/20/26Form 4Insider transaction10/27/25
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact